AIIMS Leads Historic Trial: India's First Indigenous Brain Stent Approved for Stroke

• AIIMS led India's first indigenous clinical trial (GRASSROOT) for the advanced Supernova brain stent, marking a historic achievement in stroke treatment.
• The Supernova stent, tested successfully in the GRASSROOT trial, has been approved by CDSCO for regular use in India.
• This is the first stroke device to receive approval based entirely on an Indian clinical trial, strengthening the 'Make in India' initiative.
• The stent aims to provide affordable and rapid treatment to millions, offering new hope for the 1.7 million Indians affected by stroke annually.
• Developed to suit Indian patients, the Supernova stent has already treated over 300 patients in Southeast Asia and will now be available affordably in India.

Why It Matters: India's first indigenous stroke stent approval offers affordable treatment for millions.